Delivery Order SPE2DB20D2104-SPE2DB22FR70F
Award Date 2/1/22
Potential Completion Date 2/2/22
Potential Value $1.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,191.14 for the pharmaceutical product LINZESS 290 MCG CAPSULE. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,187.16 for the pharmaceutical product LINZESS 145 MCG CAPSULE. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 23, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business category. Amerisourcebergen Drug Corp, a major pharmaceutical distributor,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,854.76 firm fixed-price delivery order is for the supply of LINZESS 145 MCG capsules. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $1,192.77 for the pharmaceutical product LINZESS 72 MCG CAPSULE UU 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 21, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,483.03 for the pharmaceutical product LINZESS 290 MCG CAPSULE UU 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of LINZESS 145 MCG CAPSULE in the amount of $4,194.90. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 7, 2023. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,560.94 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of September 20, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $9,619.08 for the supply of 4,562,145,950 capsules of the pharmaceutical product LINZESS 145 MCG. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 13, 2023. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,411.52 firm-fixed-price delivery order is for the supply of LINZESS 290 MCG capsules. The contract has an ultimate completion date of February 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., involves the delivery of LINZESS 72 MCG CAPSULE UU 30S to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order. The contract has a ceiling value of $2,674.11 and a completion date of September 21, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...